Based on these results, we speculate that SERPIND1 promoted the proliferation, migration, invasion, G1-to-S phase transition, and EMT of ovarian cancer cells as well as inhibited their apoptosis via the PI3K/AKT pathway. This evidence concerns the gene SERPIND1 and ovarian carcinoma.